The investigation revealed a concerning overlap between Dr. Jeffrey Shuren's regulatory role at the FDA and his wife’s legal work for medical device companies.
The FDA acknowledged ethical violations, stating that Dr. Shuren should have either recused himself or sought approval to avoid conflicts of interest.
Representatives Eshoo and DeLauro emphasized the need for an independent inquiry to ascertain whether the issues identified constituted actual unethical behavior.
The inspector general's office is currently reviewing the request from Congress for an investigation into the ethics of Dr. Shuren's conduct.
Collection
[
|
...
]